AbbVie (ABBV) is a publicly traded Healthcare sector company. As of September 3, 2026, ABBV trades at $260.69 with a market cap of $459.43B and a P/E ratio of 73.58. ABBV moved -0.36% today. Year to date, ABBV is +14.13%; over the trailing twelve months it is +23.53%. Its 52-week range spans $164.39 to $267.47. Analyst consensus is strong buy with an average price target of $280.10. Rallies surfaces ABBV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AbbVie (ABBV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ABBV moved -0.36% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $260.69 |
| Market Cap | $459.43B |
| P/E Ratio | 73.58 |
| EPS | $3.54 |
| Dividend Yield | 1.73% |
| 52-Week High | $267.47 |
| 52-Week Low | $164.39 |
| Volume | 1.05M |
| Avg Volume | 0 |
| Revenue (TTM) | $64.39B |
| Net Income | $6.32B |
| Gross Margin | 71.48% |
23 analysts cover ABBV: 0 strong buy, 19 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $280.10.